These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells. Mita S; Matsunaga K Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109 [TBL] [Abstract][Full Text] [Related]
7. Immunopharmacological profile of TEI-3096: a new immunomodulator. Komoriya K; Tsuchimoto M; Naruchi T; Okimura T; Yamamoto I J Immunopharmacol; 1982-1983; 4(4):285-301. PubMed ID: 6764224 [TBL] [Abstract][Full Text] [Related]
8. SA96: an immunopharmacological profile in vitro. Yamamoto I; Ohmori H; Okimura T Int J Tissue React; 1982; 4(1):1-8. PubMed ID: 7200957 [TBL] [Abstract][Full Text] [Related]
9. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells. Reinertsen JL; Steinberg AD J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957 [TBL] [Abstract][Full Text] [Related]
10. Influence of D-penicillamine on the immune response of mice. Schumacher K; Maerker-Alzer G; Schaaf W Arzneimittelforschung; 1975 Apr; 25(4):600-3. PubMed ID: 1098678 [TBL] [Abstract][Full Text] [Related]
11. A study of the mechanism of Con A-induced immunosuppression in vivo. Smith SR; Umland S; Terminelli C; Watnick AS Cell Immunol; 1984 Aug; 87(1):147-58. PubMed ID: 6234994 [TBL] [Abstract][Full Text] [Related]
12. CuSO4 as an inhibitor of B cell proliferation. Yamauchi T; Yamamoto I Jpn J Pharmacol; 1990 Dec; 54(4):455-60. PubMed ID: 2087007 [TBL] [Abstract][Full Text] [Related]
13. Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acid derivatives. II. Immunosuppressive effects. Takeshita K; Fukazawa I; Nakaike S; Kameo K; Tomisawa K; Otomo S; Aihara H Drugs Exp Clin Res; 1988; 14(5):311-8. PubMed ID: 3219994 [TBL] [Abstract][Full Text] [Related]
14. Splenic suppressor cells in adjuvant arthritic rats: effect of D-penicillamine. Binderup L; Bramm E; Arrigoni-Martelli E Agents Actions Suppl; 1980; 7():199-203. PubMed ID: 6454335 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)]. Fujimura H; Hiramatsu Y; Tamura Y; Yanagihara M; Koda A; Nagai H; Uda K; Iso T; Yamauchi H Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):117-29. PubMed ID: 6249702 [TBL] [Abstract][Full Text] [Related]
16. Immunological effects of D-penicillamine during experimental induced inflammation in rats. Binderup L; Bramm E; Arrigoni-Martelli E Scand J Immunol; 1980; 12(3):239-47. PubMed ID: 6970410 [TBL] [Abstract][Full Text] [Related]
17. D-penicillamine in vivo enhances lymphocyte DNA synthesis: role of macrophages. Binderup L; Bramm E; Arrigoni-Martelli E Scand J Immunol; 1980; 11(1):23-8. PubMed ID: 9537025 [TBL] [Abstract][Full Text] [Related]
18. Influence of dose and route of antigen injection on the immunological induction of T cells. Lagrange PH; Mackaness GB; Miller TE J Exp Med; 1974 Mar; 139(3):528-42. PubMed ID: 4591170 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo. Gregg EO; Yarwood L; Wagstaffe MJ; Pepper DS; Macdonald MC Immunology; 1990 Jun; 70(2):230-4. PubMed ID: 2142674 [TBL] [Abstract][Full Text] [Related]
20. Immunoregulation in the rat: cellular and molecular requirements for B cell responses to types 1, 2, and T-dependent antigens. Eldridge JH; Kimura S; Morisaki I; Michalek SM; Hamaoka T; Hamada S; McGhee JR J Immunol; 1985 Apr; 134(4):2236-46. PubMed ID: 2857748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]